Group 1: Company Announcements - Sanbo Neuroscience announced that it does not engage in the research, production, or sales of brain-computer interface products, and the revenue from neuroregulation technology is minimal, having little impact on its performance [1] - Xiangyu Medical stated that as of the end of 2025, its brain-computer interface products have not achieved large-scale sales, with current revenue contribution being small [1] - China Satellite Communications warned that its stock price has significantly deviated from its fundamentals, with a 108.64% increase since December 3, 2025, indicating potential short-term risks [1] - Beidou Star Communication noted that commercial aerospace is only one of the application scenarios for its products and services, with a 20% price deviation in stock trading [2] - Aerospace Huanyu expects that by 2025, revenue from commercial aerospace will account for less than 15% of its total revenue [2] - Agricultural Heart Technology reported a share reduction by Ningbo Nongqi during the stock's abnormal fluctuation period, which aligns with its disclosed reduction plan [2] Group 2: Market Reactions and Risks - Aerospace Changfeng clarified that it has not engaged in brain-computer interface or commercial aerospace businesses, and its main operations remain unchanged [3] - Weisi Medical indicated that its new products in the brain-computer interface field are still in the early market cultivation stage, with limited revenue contribution [4] - Jiamei Packaging announced a stock price increase of 230.48% since December 17, 2025, leading to a temporary suspension for investigation due to significant deviation from fundamentals [5] - WuXi AppTec reported a 2% reduction in shares by its controlling shareholders, completing its reduction plan [5] - Puni Testing expects a full-year loss for 2025, with ongoing financial assessments [6] Group 3: Performance Highlights - Pengding Holdings reported a 30.74% year-on-year increase in December revenue [7] - Honglu Steel Construction announced a 2.84% year-on-year increase in new sales contracts for 2025 [7] - Huaneng Hydropower reported a 13.32% year-on-year increase in power generation for 2025 [7] - Zhongtai Co. expects a net profit of 420 million to 480 million yuan for 2025, marking a turnaround from losses [7] - New Hope reported a 10.75% year-on-year decrease in December pig sales revenue [7] - Tianbang Foods announced an 8.95% year-on-year decline in pig sales revenue for 2025 [7]
三博脑科:目前不涉及脑机接口产品研发;16天12板嘉美包装将停牌核查丨公告精选